- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Voxar strengthens presence in U.S. and Japan
Scottish medical imaging company Voxar is planning to raise $7.5 million to fund growth in the U.S. and Japan and is considering going public sometime in the next two years.Voxar recently announced an agreement with Japanese distributor Kanagawa to
Scottish medical imaging company Voxar is planning to raise $7.5 million to fund growth in the U.S. and Japan and is considering going public sometime in the next two years.
Voxar recently announced an agreement with Japanese distributor Kanagawa to handle its medical 3-D imaging software, Plug n View, which can be used on standard PC hardware. Voxar said it expects to generate around $3 million in revenue in Japan over the next three years.
Andrew Bissell, its CEO, founded the company in 1995 in Edinburgh. Voxar has about 40 employees with offices in the U.S., Asia Pacific, and Europe, and hopes to double that staff in the near future.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
